February 2016 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2016. This roundup includes the latest...
Pre-Op Stress Tied to Post-Op Pain, Anxiety in Scoliosis Patients
In adolescents undergoing scoliosis surgery, anxiety and depression higher before procedure
Anti-VEGF Agents Linked to Visual Acuity Improvement in DME
From baseline to two years, improvement noted with three anti-VEGF agents
Drug-Induced Liver Injury From Chinese, Western Meds Varies
Cases caused by Chinese herbal medicine have more hepatocellular injury and higher mortality
Addition of Amphotericin B to Optisol-GS Needs Further Study
Authors call for more research on the addition of amphotericin B to Optisol-GS
Analysis Reveals ‘Female Libido’ Pill May Not Be Worth It
Flibanserin carries risk of serious side effects without delivering much more sexual satisfaction
Late Surfactant Does Not Cut Duration of Ventilation in BPD
But, respiratory morbidity at age one year is reduced in surfactant-treated infants
Topical Dorzolamide-Timolol Beneficial in Neovascular AMD
Findings in eyes with neovascular AMD and incomplete response to anti-VEGF therapy
Dispositional Mindfulness Tied to Improved Glucose Regulation
In adjusted analyses, no correlation for mindfulness with prevalence of type 2 diabetes
Some Women Lack Interest in Sex With New Contraceptive
Women using depot medroxyprogesterone acetate, vaginal ring, implant more likely to lack interest
